Sunil S Raikar, MD

Gender

Male

Language

English

Dr. Raikar is a Pediatric Hematologist/Oncologist at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta. He is also an Assistant Professor in the Emory University School of Medicine Department of Pediatrics.

Dr. Raikar earned his MD from St. Louis University School of Medicine in St. Louis, Mo., where he also completed his residency in pediatrics. He completed his fellowship in pediatric hematology/oncology at Emory University School of Medicine in Atlanta, Ga. Dr. Raikar is a member of the Leukemia/Lymphoma Program and the Cell and Gene Therapy Program at the Aflac Cancer Center. Additionally, he is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University.

Dr. Raikar's research interest is in the field of immunotherapy and leukemia, specifically developing chimeric antigen receptors (CAR) to target T-cell malignancies. He also has a special interest in mixed phenotypic acute leukemia (MPAL).

Locations

Aflac Cancer and Blood Disorders Center

Medical Office Building at Scottish Rite hospital, 5461 Meridian Mark Road NE Suite 400
Atlanta, GA 30342
Get Directions 404-785-1112

Aflac Cancer and Blood Disorders Center

Scottish Rite hospital, 1001 Johnson Ferry Road NE
Atlanta, GA 30342
Get Directions 404-785-5252

Aflac Cancer and Blood Disorders Center

Egleston hospital, 1405 Clifton Road NE
Atlanta, GA 30322
Get Directions 404-785-1112

Focus of Practice

  • Leukemia and lymphoma
  • Hematology/oncology

Areas of Interest

  • Chimeric antigen receptor (CAR) T-cell therapy
  • T-cell acute lymphoblastic leukemia (T-ALL)
  • Mixed phenotype acute leukemia (MPAL)

Professional Affiliations

  • American Academy of Pediatrics
  • American Society of Pediatric Hematology/Oncology
  • Children’s Oncology Group
  • American Society of Hematology
  • American Society of Gene and Cell Therapy

Research Interests

Developing novel chimeric antigen receptors (CARs) to target T-cell malignancies, studying outcomes in pediatric patients with mixed phenotype acute leukemia (MPAL)